Novian Health is a leading brand in the medical device industry, focused on providing innovative solutions for the treatment of tumors. Based in Chicago, with a subsidiary in Evry, France, Novian Health has developed the groundbreaking Novilase® Laser System. This cutting-edge, image-guided treatment enables physicians to effectively ablate tumors, offering improved outcomes and lower costs compared to traditional surgery.

Novilase Breast Therapy is one of Novian Health's flagship products, utilizing parametrically controlled heating to ablate breast tumors. This revolutionary therapy offers numerous advantages over surgery, including minimal scarring, quicker recovery, and reduced pain and fatigue. Designed by the late Dr.

Kambiz Dowlat, a renowned pioneer in breast cancer diagnosis and treatment, Novilase Breast Therapy is a minimally invasive alternative to surgery, providing a less invasive and more patient-friendly approach. Novian Health has received regulatory approvals, such as the CE Mark in Europe and FDA 510(k) clearance in the U. S., for the treatment of both malignant and benign breast tumors.

The company continues its commitment to research and development, exploring the potential application of Novilase in other tumor sites and indications. With a team of experienced and dedicated professionals, including President and CEO Henry Chip Appelbaum, Vice Presidents Eugene Bajorinas and William Graveman, and President of Novian Health SAS Julian Itzcovitz, Novian Health is at the forefront of innovation in medical devices. Additionally, Dr.

John Lewin serves as the Chief Medical Advisor, providing expert oversight to the company's clinical activities. Novian Health's mission is to improve patient outcomes and enhance the quality of life for individuals battling tumors. Through their innovative products and dedication to research, they are revolutionizing the field of tumor treatment